Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying Cognitive Benefits of its “Microdosing”… Feb 3, 2022
Study Shows Promise In Cure For Alzheimers: MYND Life Sciences Looks To Biomarkets In Fight Against Mental Disease Nov 23, 2021
MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and… Oct 27, 2021
MYND Life Sciences Working On Truly Novel Research For Depressive And Neurological Diseases Jun 24, 2021
